Delivery Order SPE2DB22D1103-SPE2DB25FTQA5
- Not listed
- The Defense Logistics Agency awarded a $10,382.17 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a cardiovascular medication used to treat heart failure. This firm fixed-price contract, awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a direct purchase from the vendor's existing Indefinite Delivery Contract with DLA. The award involved no set-aside designation and was competitively awarded. Performance will occur at...
- The Defense Logistics Agency awarded a $2,304.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a cardiac medication used to treat heart failure. The contract, which is a child order under a larger indefinite delivery vehicle, was competitively awarded without set-aside designation and is scheduled for completion by November 17, 2025. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, valued at $3,636.97. The award, made on August 26, 2025, represents a firm fixed price delivery order with an ultimate completion date of August 27, 2025. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,911.92 to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 19, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among qualified vendors in the open...
- The Defense Logistics Agency awarded a $7,357.10 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 7.5 mg, a pharmaceutical product used in heart failure treatment. This firm fixed-price delivery order, with an ultimate completion date of June 9, 2025, was awarded competitively without set-aside restrictions on June 6, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, serving as the place of performance. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,718.54 to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a cardiac medication used to treat heart failure. The award was made on September 22, 2025, under a firm fixed price contract type with an ultimate completion date of September 23, 2025. This non-set-aside delivery order was performed at the contractor's facility in Conshohocken, Pennsylvania, and represents a routine pharmaceutical procurement within the...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,457.28 for Corlanor 5 mg tablets (60-count) on September 2, 2025, with an ultimate completion date of September 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,905.32 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a pharmaceutical product used in cardiovascular treatment. This competitive award, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, represents a child delivery order executed under a larger contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,320.68 to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count units) under a firm fixed-price contract. The award, issued on November 20, 2025, with an ultimate completion date of November 21, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,701.65 to AmerisourceBergen Drug Corp for Corlanor 7.5 mg tablets (60-count) with an ultimate completion date of November 17, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the DLA's medical supply...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FTQA5Delivery Order
The Defense Logistics Agency (DLA) awarded a $7,495 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a cardiac medication used to treat heart failure. This competitively awarded, firm fixed-price contract was issued on June 17, 2025, with an ultimate completion date of June 18, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a broad portfolio of brand-name and generic medications, vaccines, and medical supplies to support military healthcare systems and other government agencies. The company's extensive contract history with DLA demonstrates its capability to fulfill diverse federal pharmaceutical procurement requirements through competitive award processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 6/17/25 |